Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Effectiveness and durability of protection against future SARS-CoV-2 infection conferred by COVID-19 vaccination and previous infection; findings from the UK SIREN prospective cohort study of healthcare workers March 2020 to September 2021

View ORCID ProfileVictoria Hall, View ORCID ProfileSarah Foulkes, Ferdinando Insalata, View ORCID ProfileAyoub Saei, View ORCID ProfilePeter Kirwan, Ana Atti, Edgar Wellington, Jameel Khawam, Katie Munro, View ORCID ProfileMichelle Cole, Caio Tranquillini, Andrew Taylor-Kerr, Nipunadi Hettiarachchi, Davina Calbraith, Noshin Sajedi, Iain Milligan, Yrene Themistocleous, Diane Corrigan, Lisa Cromey, Lesley Price, Sally Stewart, Elen de Lacy, Chris Norman, Ezra Linley, View ORCID ProfileAshley David Otter, Amanda Semper, Jacqueline Hewson, Silvia D’Arcangelo, the SIREN Study Group, Meera Chand, Colin S Brown, Tim Brooks, Jasmin Islam, View ORCID ProfileAndre Charlett, Susan Hopkins
doi: https://doi.org/10.1101/2021.11.29.21267006
Victoria Hall
1UK Health Security Agency
2The National Institute for Health Research Health Protection Research (NIHR) Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Victoria Hall
Sarah Foulkes
1UK Health Security Agency
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sarah Foulkes
Ferdinando Insalata
1UK Health Security Agency
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ayoub Saei
1UK Health Security Agency
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ayoub Saei
Peter Kirwan
1UK Health Security Agency
3Medical Research Council Biostatistics Unit, University of Cambridge
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter Kirwan
Ana Atti
1UK Health Security Agency
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edgar Wellington
1UK Health Security Agency
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jameel Khawam
1UK Health Security Agency
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katie Munro
1UK Health Security Agency
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle Cole
1UK Health Security Agency
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michelle Cole
Caio Tranquillini
1UK Health Security Agency
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Taylor-Kerr
1UK Health Security Agency
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nipunadi Hettiarachchi
1UK Health Security Agency
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Davina Calbraith
1UK Health Security Agency
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noshin Sajedi
1UK Health Security Agency
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Iain Milligan
1UK Health Security Agency
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yrene Themistocleous
1UK Health Security Agency
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diane Corrigan
4Public Health Agency Northern Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa Cromey
4Public Health Agency Northern Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lesley Price
5Glasgow Caledonian University
6Public Health Scotland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sally Stewart
5Glasgow Caledonian University
6Public Health Scotland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elen de Lacy
7Public Health Wales
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chris Norman
8Health and Care Research Wales
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ezra Linley
1UK Health Security Agency
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashley David Otter
1UK Health Security Agency
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ashley David Otter
Amanda Semper
1UK Health Security Agency
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacqueline Hewson
1UK Health Security Agency
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silvia D’Arcangelo
1UK Health Security Agency
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meera Chand
1UK Health Security Agency
9Guys and Thomas’s NHS Trust
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Colin S Brown
1UK Health Security Agency
2The National Institute for Health Research Health Protection Research (NIHR) Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tim Brooks
1UK Health Security Agency
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jasmin Islam
1UK Health Security Agency
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andre Charlett
1UK Health Security Agency
10NIHR Health Protection Research Unit in Behavioural Science and Evaluation at University of Bristol in partnership with Public Health England
11NIHR Health Protection Research Unit in Immunisation at the London School of Hygiene and Tropical Medicine in partnership with Public Health England
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andre Charlett
Susan Hopkins
1UK Health Security Agency
2The National Institute for Health Research Health Protection Research (NIHR) Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: susan.hopkins@phe.gov.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Understanding the duration and effectiveness of infection and vaccine-acquired SARS-CoV-2 immunity is essential to inform pandemic policy interventions, including the timing of vaccine-boosters. We investigated this in our large prospective cohort of UK healthcare workers undergoing routine asymptomatic PCR testing.

Methods We assessed vaccine effectiveness (VE) (up to 10-months after first dose) and infection-acquired immunity by comparing time to PCR-confirmed infection in vaccinated and unvaccinated individuals using a Cox regression-model, adjusted by prior SARS-CoV-2 infection status, vaccine-manufacturer/dosing-interval, demographics and workplace exposures.

Results Of 35,768 participants, 27% (n=9,488) had a prior SARS-CoV-2 infection. Vaccine coverage was high: 97% had two-doses (79% BNT162b2 long-interval, 8% BNT162b2 short-interval, 8% ChAdOx1). There were 2,747 primary infections and 210 reinfections between 07/12/2020 and 21/09/2021. Adjusted VE (aVE) decreased from 81% (95% CI 68%-89%) 14-73 days after dose-2 to 46% (95% CI 22%-63%) >6-months; with no significant difference for short-interval BNT162b2 but significantly lower aVE (50% (95% CI 18%-70%) 14-73 days after dose-2 from ChAdOx1. Protection from infection-acquired immunity showed evidence of waning in unvaccinated follow-up but remained consistently over 90% in those who received two doses of vaccine, even in those infected over 15-months ago.

Conclusion Two doses of BNT162b2 vaccination induce high short-term protection to SARS-CoV-2 infection, which wanes significantly after six months. Infection-acquired immunity boosted with vaccination remains high over a year after infection. Boosters will be essential to maintain protection in vaccinees who have not had primary infection to reduce infection and transmission in this population.

Trial registration number ISRCTN11041050

Competing Interest Statement

The authors have declared no competing interest.

Clinical Protocols

https://www.medrxiv.org/content/10.1101/2020.12.15.20247981v1

Funding Statement

The study is funded by the Department for Health and Social Care and UKHSA (formerly PHE) with contributions from the governments of Northern Ireland, Scotland and Wales. Funding was also provided by The National Institute for Health Research (NIHR) as an Urgent Public Health Priority Study and through the Health Protection Research Units. The study was also awarded grant funding from the Medical Research Council (Grant title: Investigation of proven vaccine breakthrough by SARS-CoV-2 variants in established UK healthcare worker cohorts: SIREN consortium & PITCH Plus Pathway).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was registered, number ISRCTN11041050, and received approval from the Berkshire Research Ethics Committee on 22 May 2020.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • □ SIREN study group names provided in supplementary material

Data Availability

Annotated code for this analysis is available at: (https://github.com/SIREN-study/SARS-CoV-2-Immunity). The metadata for this analysis will be available to researchers through the Health Data Research UK CO-CONNECT platform and available for secondary analysis.

https://github.com/SIREN-study/SARS-CoV-2-Immunity

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted December 01, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Effectiveness and durability of protection against future SARS-CoV-2 infection conferred by COVID-19 vaccination and previous infection; findings from the UK SIREN prospective cohort study of healthcare workers March 2020 to September 2021
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Effectiveness and durability of protection against future SARS-CoV-2 infection conferred by COVID-19 vaccination and previous infection; findings from the UK SIREN prospective cohort study of healthcare workers March 2020 to September 2021
Victoria Hall, Sarah Foulkes, Ferdinando Insalata, Ayoub Saei, Peter Kirwan, Ana Atti, Edgar Wellington, Jameel Khawam, Katie Munro, Michelle Cole, Caio Tranquillini, Andrew Taylor-Kerr, Nipunadi Hettiarachchi, Davina Calbraith, Noshin Sajedi, Iain Milligan, Yrene Themistocleous, Diane Corrigan, Lisa Cromey, Lesley Price, Sally Stewart, Elen de Lacy, Chris Norman, Ezra Linley, Ashley David Otter, Amanda Semper, Jacqueline Hewson, Silvia D’Arcangelo, the SIREN Study Group, Meera Chand, Colin S Brown, Tim Brooks, Jasmin Islam, Andre Charlett, Susan Hopkins
medRxiv 2021.11.29.21267006; doi: https://doi.org/10.1101/2021.11.29.21267006
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Effectiveness and durability of protection against future SARS-CoV-2 infection conferred by COVID-19 vaccination and previous infection; findings from the UK SIREN prospective cohort study of healthcare workers March 2020 to September 2021
Victoria Hall, Sarah Foulkes, Ferdinando Insalata, Ayoub Saei, Peter Kirwan, Ana Atti, Edgar Wellington, Jameel Khawam, Katie Munro, Michelle Cole, Caio Tranquillini, Andrew Taylor-Kerr, Nipunadi Hettiarachchi, Davina Calbraith, Noshin Sajedi, Iain Milligan, Yrene Themistocleous, Diane Corrigan, Lisa Cromey, Lesley Price, Sally Stewart, Elen de Lacy, Chris Norman, Ezra Linley, Ashley David Otter, Amanda Semper, Jacqueline Hewson, Silvia D’Arcangelo, the SIREN Study Group, Meera Chand, Colin S Brown, Tim Brooks, Jasmin Islam, Andre Charlett, Susan Hopkins
medRxiv 2021.11.29.21267006; doi: https://doi.org/10.1101/2021.11.29.21267006

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (160)
  • Allergy and Immunology (413)
  • Anesthesia (90)
  • Cardiovascular Medicine (855)
  • Dentistry and Oral Medicine (159)
  • Dermatology (97)
  • Emergency Medicine (248)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (393)
  • Epidemiology (8550)
  • Forensic Medicine (4)
  • Gastroenterology (383)
  • Genetic and Genomic Medicine (1744)
  • Geriatric Medicine (167)
  • Health Economics (371)
  • Health Informatics (1237)
  • Health Policy (619)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (372)
  • Infectious Diseases (except HIV/AIDS) (10281)
  • Intensive Care and Critical Care Medicine (552)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (210)
  • Neurology (1670)
  • Nursing (97)
  • Nutrition (248)
  • Obstetrics and Gynecology (325)
  • Occupational and Environmental Health (450)
  • Oncology (926)
  • Ophthalmology (263)
  • Orthopedics (100)
  • Otolaryngology (172)
  • Pain Medicine (112)
  • Palliative Medicine (40)
  • Pathology (252)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (247)
  • Primary Care Research (207)
  • Psychiatry and Clinical Psychology (1764)
  • Public and Global Health (3832)
  • Radiology and Imaging (622)
  • Rehabilitation Medicine and Physical Therapy (319)
  • Respiratory Medicine (520)
  • Rheumatology (207)
  • Sexual and Reproductive Health (165)
  • Sports Medicine (157)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (74)